|Day Low/High||300.50 / 314.28|
|52 Wk Low/High||187.72 / 310.12|
A slide in Goldman Sachs and UnitedHealth shares pull the Dow lower by nearly triple digits.
TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on Tuesday's trending stocks.
Cramer is fond of UnitedHealth's latest quarter.
It's Report Week: Keep an Eye on the Big Companies
Senate leader Mitch McConnell says he will kill the healthcare bill after two more Senators said they would vote against it.
Bulletproof coffee in hand, a quick scan of the markets shows the futures up ever so slightly as investors grapple with the realization the GOP is giving up on replacing the Affordable Care Act and is turning to repealing it. That news is pressuring...
What to expect from United Continental, UnitedHealth and Lockheed Martin's earnings.
As always, it was good seeing everyone on the Daily Diary sitting in for Doug Kass. Lots of good conversation despite a quiet day in the market with the market indices ending the day pretty much where they started. Very narrow range of trading throu...
Procter & Gamble proxy fight is an intriguing distraction.
Changes in economy have shored up weak areas.
Here comes some volatility in the markets.
The Senate just unveiled more details about its health care reform bill.
We forget that a big hedge fund or mutual fund switching out of tech winners into everything else can roil the market.
From price momentum to signs of irrational exuberance, several things have me worried.
These three stocks are showing short-term gain catalysts and longer-term growth potential.
It's a wonder to me how split this market really is.
Stocks closed lower after digesting mixed first quarter earnings data.
So far, the biggest in whatever sectors have benefited the most from his presidency.
Repatriation of profits would bring in money and tax revenue.
British Prime Minister Theresa May is calling for a 'snap' or general election on June 8th.
Goldman Sachs and Bank of America release earnings on Tuesday.
Their overseas business has been carrying them.
Neither the Affordable Care Act nor the American Health Care Act did enough to address rising health-care costs.
Take a closer look at four stocks professional investors are loving in 2017.
This reversal has been incredible to watch.
Healthcare stocks had a heckuva four-year period of over-performance that ended in the summer of 2015. Since then the Health Care Select Sector SPDR ETF (40% pharma and 15% biotech) has had a series of trading-range moves as sector prices lagged. La...